Genome & Company Restructures Management System Centered on Board of Directors and Professional Managers

On March 26, Genome & Company announced that it has transitioned to a management system centered around the board of directors and professional managers, following resolutions at its general shareholders’ meeting and board meeting.

With this restructuring, founder Kwangpyo Ko has shifted to the role of Chief Visionary Officer (CVO), focusing on establishing the company’s mid- to long-term vision, while newly appointed CEO Hanseung Lee will be responsible for overseeing all aspects of management.

CVO Kwangpyo Ko is set to concentrate on establishing the company’s mid- to long-term technology agenda, global growth strategies, and business vision. The company explained that it has established a structure in which the CVO oversees the mid- to long-term vision and future technology development direction, while the CEO is responsible for strategy execution and delivering business performance, thereby enhancing operational effectiveness through clear division of roles. In addition, to reinforce an objective, board-centered decision-making system, CVO Kwangpyo Ko will not participate in the board after the expiration of his current term as director.

Newly appointed CEO Hanseung Lee previously worked for 20 years as an expert in research and development and business commercialization at LG Chem (formerly LG Life Sciences). Since joining Genome & Company, he has served as COO for the past three years, ensuring stable operations.

After the recent general shareholders’ meeting, Genome & Company expanded its board to a seven-member structure by bringing in both internal and external experts across investment, management, and research fields. The company expects that this expert-centered board composition will enhance the credibility of its governance structure and provide a foundation for Genome & Company’s technological value to be more fairly evaluated in the capital market.

A Genome & Company representative stated, “This management restructuring aims to generate synergy between the founder’s scientific insight and the professional manager’s execution capabilities within their respective areas of expertise.” The representative added, “CVO Kwangpyo Ko will focus on establishing the mid- to long-term vision and future technology roadmap, while CEO Hanseung Lee will be responsible for executing business strategies and delivering results.”

This content was produced with the assistance of AI translation services.